Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.
about
Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review.Asthma Phenotypes and Endotypes: Implications for Personalised Therapy.A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis.
P2860
Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Nebulised liposomal amphoteric ...... series and literature review.
@en
type
label
Nebulised liposomal amphoteric ...... series and literature review.
@en
prefLabel
Nebulised liposomal amphoteric ...... series and literature review.
@en
P2093
P2860
P50
P356
P1433
P1476
Nebulised liposomal amphoteric ...... series and literature review.
@en
P2093
Cendrine Godet
François Laurent
Gwenaël Le Moal
Jacques Cadranel
Jean-Pierre Frat
Valérie Gounant
Véronique Goudet
P2860
P304
P356
10.1111/MYC.12294
P577
2015-03-01T00:00:00Z